CrystalGenomics Inc (083790) - Total Liabilities

Latest as of September 2025: ₩124.24 Billion KRW ≈ $84.20 Million USD

Based on the latest financial reports, CrystalGenomics Inc (083790) has total liabilities worth ₩124.24 Billion KRW (≈ $84.20 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CrystalGenomics Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how CrystalGenomics Inc's total liabilities have evolved over time, based on quarterly financial data. See CrystalGenomics Inc (083790) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

CrystalGenomics Inc Competitors by Total Liabilities

The table below lists competitors of CrystalGenomics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
PLYTEC Holding Berhad KLSE:0289	Malaysia	RM139.42 Million
Athira Pharma Inc NASDAQ:ATHA	USA	$64.36 Million
Worth Peripherals Limited NSE:WORTH	India	Rs387.40 Million
Killi Resources Ltd AU:KLI	Australia	AU$90.10K
Syntara Ltd AU:SNT	Australia	AU$5.42 Million
Cue Biopharma NASDAQ:CUE	USA	$18.40 Million
Mida Assets Public Company Limited BK:MIDA	Thailand	฿7.38 Billion
Inmobiliaria Park Rose Iberoamericana SOCIMI SA MC:YPARK	Spain	€11.04 Million

Liability Composition Analysis (2011–2024)

This chart breaks down CrystalGenomics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CrystalGenomics Inc (083790) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.45	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.82	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.59	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CrystalGenomics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CrystalGenomics Inc (2011–2024)

The table below shows the annual total liabilities of CrystalGenomics Inc from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩161.95 Billion ≈ $109.75 Million	+65.55%
2023-12-31	₩97.82 Billion ≈ $66.29 Million	-27.18%
2022-12-31	₩134.34 Billion ≈ $91.04 Million	+7.39%
2021-12-31	₩125.09 Billion ≈ $84.77 Million	+22.39%
2020-12-31	₩102.20 Billion ≈ $69.26 Million	-55.59%
2019-12-31	₩230.14 Billion ≈ $155.96 Million	+217.64%
2018-12-31	₩72.45 Billion ≈ $49.10 Million	+159.89%
2017-12-31	₩27.88 Billion ≈ $18.89 Million	-38.74%
2016-12-31	₩45.51 Billion ≈ $30.84 Million	-17.77%
2015-12-31	₩55.34 Billion ≈ $37.51 Million	+8.47%
2014-12-31	₩51.02 Billion ≈ $34.58 Million	-3.01%
2013-12-31	₩52.61 Billion ≈ $35.65 Million	+62.91%
2012-12-31	₩32.29 Billion ≈ $21.88 Million	-0.92%
2011-12-31	₩32.59 Billion ≈ $22.09 Million	--

About CrystalGenomics Inc

KQ:083790 Korea Pharmaceuticals

Market Cap

$26.59 Million

₩39.24 Billion KRW

Market Cap Rank

#24223 Global

#1687 in Korea

Share Price

₩970.00

Change (1 day)

+4.30%

52-Week Range

₩779.00 - ₩1925.00

All Time High

₩18365.04